You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

high residual risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Digital Droplet PCR in Early Period After Allo-HSCT to Predict

Completed
  • Measurable Residual Disease
  • Digital Droplet PCR
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 17, 2023

Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)

Not yet recruiting
  • Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
  • Monalizumab
  • Cetuximab
  • (no location specified)
Jan 8, 2023

High Risk CLL, Chronic Lymphocytic Leukemia Trial (VenObi+Ven or VenObi+VenZan)

Not yet recruiting
  • High Risk CLL
  • Chronic Lymphocytic Leukemia
  • VenObi+Ven or VenObi+VenZan
  • (no location specified)
Jul 26, 2022

Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • (no location specified)
Nov 15, 2023

Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 31, 2023

Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

Recruiting
  • Gastrointestinal Stromal Tumors
  • Minimal Residual Disease
  • liquid biopsy
  • Beijing, Beijing, China
    Peking University People'S Hospital
Sep 18, 2022

Breast, Metastatic, Triple Negative Trial in Gainesville, Jacksonville (Capecitabine, Sarilumab 150mg or 200 mg plus

Active, not recruiting
  • Breast
  • +4 more
  • Gainesville, Florida
  • +1 more
Feb 2, 2023

Myeloma Multiple Trial in Orange, Nashville (Descartes 08)

Recruiting
  • Myeloma Multiple
  • Descartes 08
  • Orange, California
  • +1 more
Apr 4, 2022

Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Discontinuation of maintenance treatment
  • Cork, Ireland
    Cork University Hospital
May 10, 2023

Barrett Oesophagitis With Dysplasia Trial in Kansas City (Itraconazole in capsule form, Itraconazole in solution form)

Recruiting
  • Barrett Oesophagitis With Dysplasia
  • Itraconazole in capsule form
  • Itraconazole in solution form
  • Kansas City, Kansas
    University of Kansas Medical Center
Nov 1, 2022

Myeloma Multiple Trial in United States (Descartes 11)

Completed
  • Myeloma Multiple
  • Descartes 11
  • Bethesda, Maryland
  • +3 more
Mar 10, 2022

ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck

Active, not recruiting
  • Cancer
  • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 7, 2022

    Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Trial in Duarte (drug, other,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Feb 17, 2022

    Colorectal Cancer Trial in Helsinki, Tampere (drug, diagnostic test, radiation)

    Recruiting
    • Colorectal Cancer
    • Total neoadjuvant therapy (TNT)
    • +2 more
    • Helsinki, Uusimaa, Finland
    • +1 more
    Dec 31, 2021

    Percutaneous Coronary Intervention, Multivessel Coronary Artery Disease, Elderly Patients Trial in Beijing (colchicine)

    Not yet recruiting
    • Percutaneous Coronary Intervention
    • +3 more
    • Beijing, Beijing, China
      Fuwai Hospital, National Center for Cardiovascular Diseases, CAM
    Sep 1, 2023

    Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL Trial in Spain (blinatumomab)

    Terminated
    • Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
    • Badalona, Barcelona, Spain
    • +11 more
    Jul 26, 2022

    Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker

    Completed
    • Acute Myeloid Leukemia
    • +4 more
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    May 12, 2021

    Type 1 Diabetes, Cardiovascular Diseases, Chronic Inflammation Trial in Hellerup (Colchicine 0.5 MG Oral Tablet, Placebo)

    Not yet recruiting
    • Type 1 Diabetes
    • +2 more
    • Colchicine 0.5 MG Oral Tablet
    • Placebo
    • Hellerup, Capital Region, Denmark
      Center for Clinical Metabolic Research, Gentofte Hospital
    Jul 7, 2023

    Type 2 Diabetes Trial in Amsterdam (Semaglutide, 2.0 mg/mL)

    Not yet recruiting
    • Type 2 Diabetes
    • Semaglutide, 2.0 mg/mL
    • Amsterdam, Noord-Holland, Netherlands
      AMC
    Oct 26, 2022

    Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

    Not yet recruiting
    • Ovarian Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 9, 2023

    Infant, Premature, Diseases, Respiratory Distress Syndrome Trial in Zurich (High Flow)

    Recruiting
    • Infant, Premature, Diseases
    • Respiratory Distress Syndrome
    • High Flow
    • Zurich, Switzerland
      Newborn Research, Department of Neonatology, University Hospital
    May 16, 2022

    Metabolism, Trauma, Nutritional Deficiency Trial in Bucharest (Medical food)

    Not yet recruiting
    • Metabolism
    • +6 more
    • Medical food
    • Bucharest, Romania
      Clinical Emergency Hospital of Bucharest
    Dec 2, 2022

    Breast Cancer Trial in United States (Placebo, GLSI-100)

    Recruiting
    • Breast Cancer
    • Placebo
    • GLSI-100
    • Birmingham, Alabama
    • +21 more
    Jan 30, 2023

    B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

    Not yet recruiting
    • B Acute Lymphoblastic Leukemia
    • +2 more
    • Azacitidine Injection
    • +2 more
    • (no location specified)
    Oct 15, 2023

    Type 1 Diabetes Trial in Shanghai (Cholecalciferol (Vit D3) 400Unit Cap)

    Not yet recruiting
    • Type 1 Diabetes
    • Cholecalciferol (Vit D3) 400Unit Cap
    • Shanghai, China
      Department of Pediatrics, Ruijin Hospital, Shanghai Jiao Tong Un
    May 20, 2022